Co-existence of TBCK encephalopathy and medium/short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (M/SCHAD) in a Puerto Rican girl
Open Access
- 21 August 2026
- journal article
- Published by The International Child Neurology Association in Journal of the International Child Neurology Association
- Vol. 1 (1)
Abstract
We report the case of a Puerto Rican girl who presented with multiple seizure types, epileptic spasms and severe global developmental delay. Her examination was significant for myopathic face, profound hypotonia, and areflexia. Her genetic workup revealed a homozygous pathogenic c.376C>T (p.R126X) mutation in the TBCK gene. A second homozygous likely pathogenic c.908G>T (p.G303V) mutation in the HADH gene, responsible for medium/short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (M/SCHAD), was also found. Her seizures responded dramatically to IV methylprednisolone infusions, and she has remained stable without metabolic crisis.Keywords
This publication has 12 references indexed in Scilit:
- Homozygous boricua TBCK mutation causes neurodegeneration and aberrant autophagyAnnals of Neurology, 2017
- TBCK‐related intellectual disability syndrome: Case study of two patientsAmerican Journal of Medical Genetics Part A, 2016
- Mutations in TBCK, Encoding TBC1-Domain-Containing Kinase, Lead to a Recognizable Syndrome of Intellectual Disability and HypotoniaThe American Journal of Human Genetics, 2016
- Recessive Inactivating Mutations in TBCK, Encoding a Rab GTPase-Activating Protein, Cause Severe Infantile Syndromic EncephalopathyThe American Journal of Human Genetics, 2016
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort studyThe Lancet, 2007
- 3‐Hydroxyacyl‐CoA dehydrogenase and short chain 3‐hydroxyacyl‐CoA dehydrogenase in human health and diseaseThe FEBS Journal, 2005
- The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trialThe Lancet, 2004
- Fatal Hepatic Short-Chain l-3-Hydroxyacyl-Coenzyme a Dehydrogenase Deficiency: Clinical, Biochemical, and Pathological Studies on Three Subjects with This Recently Identified Disorder of Mitochondrial β-OxidationPediatric and Developmental Pathology, 1999
- Short‐chainL‐3‐hydroxyacyl‐CoA dehydrogenase deficiency in muscle: A new cause for recurrent myoglobinuria and encephalopathyAnnals of Neurology, 1991